Edition:
United Kingdom

People: Bruker Corp (BRKR.OQ)

BRKR.OQ on NASDAQ Stock Exchange Global Select Market

48.48USD
17 Jul 2019
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$48.48
Open
$48.50
Day's High
$48.98
Day's Low
$48.26
Volume
501,298
Avg. Vol
283,987
52-wk High
$51.35
52-wk Low
$26.11

Busse, Falko 

Dr. Falko Busse. Ph.D., is President, Bruker BioSpin Group of the Company, Dr. Busse has served as President of the Bruker BioSpin Group since May 2018, with responsibility for management of its global operations. Dr. Busse served as Deputy President of the Bruker BioSpin Group from October 2017 until his appointment as President. From March 2017 to September 2017, Dr. Busse served as Executive Vice President of Research and Development, Operations and Marketing at the Bruker BioSpin Group. Dr. Busse joined the Bruker BioSpin Group in June 2015 and served as Executive Vice President of Research and Development until February 2017. Prior to joining the Bruker BioSpin Group, Dr. Busse served in various managerial roles at Philips Healthcare and its subsidiaries from August 1994 until May 2015, including as General Manager Radiology Solutions, from January 2014 to May 2015, and as General Manager MR-Therapy, from August 2009 to December 2013. Dr. Busse holds a B.A. and a Ph.D. in Physics from Rheinische Friedrich-Wilhelms-Universitat Bonn.

Basic Compensation

Total Annual Compensation, USD 339,467
Restricted Stock Award, USD 133,324
Long-Term Incentive Plans, USD --
All Other, USD 226,454
Fiscal Year Total, USD 699,245

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Frank Laukien

4,479,900

Gerald Herman

1,026,520

Falko Busse

699,245

Burkhard Prause

967,913

Juergen Srega

1,390,790

Mark Munch

1,820,810
As Of  31 Dec 2018